About Phylos Bioscience
Phylos Bioscience is a Healthcare company based in Portland (United States) founded in 2014 by Nishan Karassik. Developer of cannabis breeding tools for agriculture other health purposes. It operates in the Healthcare and Agriculture sectors. Phylos Bioscience has raised $32 million across 12 funding rounds from investors including Organigram, Merida Capital Partners and Accomplice. The company has 61 employees. Its website phylos.bio draws about 14 thousand monthly visits. Phylos Bioscience offers products and services including F1 Hybrid Seeds and Natural THCV Products. Its focus areas include Life Sciences, Genomics, Applied Genomics and Agrigenomics. Its legal entity is Phylos Bioscience, Inc. Its competitors include Benson Hill, Cibus and Pairwise; 3 of its 3 listed competitors have raised funding.
Company details
Phylos Bioscience was founded in 2014 in Portland, United States, within the biotechnology sector focused on cannabis. Tools for plant breeding and sex testing are offered, including kits and cards that detect the Y chromosome in plants aged seven to ten days. Services encompass genetic diagnostics, data analysis, and breeding resources tailored to cannabis cultivation for agricultural and health applications. Operations are centered on transformative plant genetics.
- Headquarters Portland, United States
- Employees 61
- Founders Nishan Karassik
- SectorsHealthcareAgriculture
- Website category Health · Addictions
- Email••••••••
- Phone•••• ••••
- Website phylos.bio
- Social LinkedIn X Facebook
- Legal Name Phylos Bioscience, Inc.
- Total Equity Funding$32M (USD)
in 12 rounds
- Latest Funding Round$3M (USD), Series B
Dec 2025
- InvestorsOrganigram
& 3 more
- Employee Count61
Products & Services of Phylos Bioscience
Phylos Bioscience offers a comprehensive portfolio of products and services, including F1 Hybrid Seeds and Natural THCV Products.
Seeds for high-THC cannabis with uniform growth and cost savings.
Enhances cannabis cultivation with unique aromas and traits.
Funding Insights of Phylos Bioscience
Phylos Bioscience has successfully raised a total of $32M across 12 strategic funding rounds. The most recent funding activity was a Series B round of $3 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $32M
- Total Rounds 12
- Last Round Series B — $3M
- First Round $250,000
(Jan 2015)
- Investors Count 4
Latest 10 of 12 funding rounds of Phylos Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2025 | $3M | Series B | – | – | |
| Dec 2025 | $583,418 | Series B | – | – | – |
| Oct 2024 | $1.81M | Series D | – | – | – |
| Nov 2023 | $150,000 | Series C | – | – | – |
| May 2023 | Series C | – | – | ||
| Feb 2022 | $7.6M | Series C | – | Merida Capital Partners | |
| Apr 2021 | $12.16M | Series C | – | – | – |
| Jan 2021 | $4.52M | Series B | – | – | – |
| Dec 2017 | $250,000 | Seed | – | – | – |
| Sep 2016 | $1.43M | Series A | – | – | – |
4 investors in total: 4 institutional.
Investors in Phylos Bioscience
Phylos Bioscience has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Organigram, Merida Capital Partners and Accomplice.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| meridacap.com | ||||
Accomplice is engaged in venture capital investments for startups. | accomplice.co | Boston, United States | ||
Investment firm focused on cannabis industry growth and leadership. | 2014 | entourageeffectcapital.com | ||
Provider of cannabis products, brands, and international business development investments | 2013 | organigram.ca | Moncton, Canada |
Investor details for Phylos Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Phylos Bioscience
27 people are tracked at Phylos Bioscience (14 in leadership, 10 in board & advisors, 3 in team); the tracked headcount is 61.
| Name | Role | Group |
|---|---|---|
Nishan Karassik | Co-Founder | Leadership |
John McFerson | VP, Breeding | Leadership |
Ralph Risch | Chief Executive Officer | Leadership |
Alisha Holloway | Chief Scientific Officer | Leadership |
Barbara Peachey | Chief Financial Officer | Leadership |
Erica Bakker | Senior Director of Gene Discovery | Leadership |
Jessica Lewis | Human Resources Director | Leadership |
Damon Hess | VP, Sales | Leadership |
Jared Reynbery | Senior Director Of Breeding | Leadership |
Erik Jackson | Regional Sales Director | Leadership |
Benjamin Adams | Director Of Business Development | Leadership |
Scott Hanes | Regional Sales Director | Leadership |
Benjamin A. | Director Of Business Development | Leadership |
Whitney Conroy | Chief Commercial Officer | Leadership |
Lukas Mueller | Larry Smart, PhD | Board & advisors |
Sue Rhee | Advisor | Board & advisors |
Glenda Anderson | Advisor | Board & advisors |
Jeanne Sullivan | Advisor | Board & advisors |
Gail Taylor | Advisor | Board & advisors |
Timothy Gregory | Advisor | Board & advisors |
7 more people are available in the full profile.
Complete people profiles for Phylos Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Phylos Bioscience
3 dated milestones of Phylos Bioscience across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Phylos Bioscience is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Series B, of $3.0M.
Competitors of Phylos Bioscience
Phylos Bioscience has 3 listed competitors in our database, 3 of them funded. They include Benson Hill, Cibus and Pairwise.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bensonhill.com | 2012 | St. Louis, United States | $406.99M | 151 | Provider of plant-based food ingredients | |
| cibus.com | 2001 | San Diego, United States | $34.47M | 129 | Gene editing solutions are provided for agriculture. | |
| pairwise.com | 2017 | Durham, United States | $155M | New crop varieties are developed using gene-editing for agrigenomics. |
Detailed competitors of Phylos Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Phylos Bioscience
The website of Phylos Bioscience (phylos.bio) receives about 14K visits a month and ranks #1,870,250 among all websites worldwide, #2,194 in Addictions.
- Monthly visits14K
▲ 14.4% vs previous month
- Unique visitors5.2K
per month
- Global rank#1,870,250
among all websites
- Category rank#2,194
Health · Addictions
- Bounce rate50%
- Pages per visit2.2
- Average visit41 sec
- DevicesDesktop 17% · Mobile 83%
Websites whose visitors overlap most with Phylos Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
dankseed.store | dankseed.store | 100% | #11,408,843 | – | |
| theorywellness.org | 79% | 125.4K | #225,240 | View details | |
| getfluent.com | 77% | 413.6K | #81,099 | View details | |
overgrow.com | overgrow.com | 77% | #117,132 | – | |
| risecannabis.com | 46% | #27,863 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Phylos Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Phylos Bioscience (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Phylos Bioscience
Complete news archive for Phylos Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Phylos Bioscience
Phylos Bioscience was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Phylos Bioscience is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
Phylos Bioscience is a funded company, having raised a total of $32M across 12 funding rounds to date. The company's 1st funding round was a Series A of $1.43M, raised on Jan 2015.
Phylos Bioscience has 61 employees.
Phylos Bioscience was founded in 2014 in Portland, United States, within the biotechnology sector focused on cannabis. Tools for plant breeding and sex testing are offered, including kits and cards that detect the Y chromosome in plants aged seven to ten days. Services encompass genetic diagnostics, data analysis, and breeding resources tailored to cannabis cultivation for agricultural and health applications. Operations are centered on transformative plant genetics.
Phylos Bioscience's top competitors include Benson Hill, Cibus and Pairwise.
Phylos Bioscience offers F1 Hybrid Seeds and Natural THCV Products.
Phylos Bioscience has 4 investors. Key investors include Organigram, Merida Capital Partners, Accomplice, and Entourage Effect Capital.
Phylos Bioscience operates through Phylos Bioscience, Inc..